Is gain of GRHL2 associated with early recurrence of hepatocellular carcinoma?
A gain of GRHL2 might be a predictive marker for HCC recurrence.
We found no significant difference in QRS score between the ischemic primary and secondary prevention groups. Therefore, a role of the Selvester QRS score as a risk stratifier remains unlikely.